New imaging techniques to evaluate pancreatic cancer treatment response
Surrogate biomarkers for assessing changes in pancreatic cancer tumor microenvironment
This study is looking at new ways to use imaging techniques to see how well pancreatic cancer treatments are working, so doctors can better decide which patients are ready for surgery after their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10870037 on NIH RePORTER |
What this research studies
This research focuses on improving the assessment of pancreatic cancer treatment responses by developing new imaging biomarkers. It aims to combine various imaging techniques before, during, and after surgery to better understand how tumors respond to neoadjuvant therapies. By using advanced methods to measure tumor characteristics, the research seeks to provide more accurate evaluations than traditional size measurements. This could help identify which patients are suitable for surgery after treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with borderline resectable pancreatic ductal adenocarcinoma who are undergoing neoadjuvant therapies.
Not a fit: Patients with fully resectable pancreatic cancer or those with advanced metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for pancreatic cancer, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer assessment, indicating potential success for this novel approach.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Doyley, Marvin M — University of Rochester
- Study coordinator: Doyley, Marvin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.